BioSpace News Archive

Pillar Biosciences today announced the appointment of Randy Pritchard as Chief Executive Officer.

Precigen, Inc. today announced Helen Sabzevari , PhD, President and CEO of Precigen, will participate in two upcoming conferences.

Bryn Pharma, LLC today announced the appointment of Anne Clem Whitaker to its Board of Directors, effective immediately.

InterVenn Biosciences today announced that it will be participating via webcast in the Morgan Stanley 19th Annual Global Healthcare Conference.

Endosound, Inc. announced today that its EndoSound Vision System received a Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).

Quotient Limited, a commercial-stage diagnostics company, headquartered in Eysins, Switzerland, announced that Christian Albrich has been appointed as Chief People Officer of the Company.

GE Healthcare introduced the AMX Navigate,1 a new portable, digital X-ray system designed with a first-of-its-kind power-assisted Free Motion telescoping column that aims to reduce lift force by up to 70 percent2 and decrease technologist injury.

ABVC BioPharma, Inc. today announced it has filed new PCT (Patent Cooperation Treaty) applications in connection with its medicines that treat major depressive disorder (MDD) and Attention-Deficit Hyperactivity Disorder (ADHD).

For two years, Critical Path Institute, the National Organization for Rare Disorders and the U.S. Food and Drug Administration have joined with others throughout the rare disease community to create a novel, best-in-class platform to accelerate rare disease treatment innovation.

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal imbalance, today announced that management will participate in the ‘Emerging Therapies for Psychiatric Disorders’ panel at Citi’s 16th Annual BioPharma Virtual Conference.